ELVN vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

ELVN

32.5
AI Score
VS
RXRX Wins

RXRX

50.4
AI Score

Investment Advisor Scores

ELVN

33score
Recommendation
SELL

RXRX

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ELVN RXRX Winner
Net Income -83.81M -644.76M ELVN
Operating Income -101.08M -648.13M ELVN
ROE -9.6% -57.0% ELVN
ROA -9.3% -43.7% ELVN
Total Assets 897.23M 1.47B RXRX
Cash 151.67M 743.29M RXRX
Current Ratio 45.95 5.50 ELVN

Relative Price Performance (Last 90 Days)

ELVN 1M: +29.6% · 3M: -11.8% RXRX 1M: -6.4% · 3M: +8.5%

Current Technical Phase

ELVN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.2 · Price: $51.19

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.1 · Price: $3.59

Fundamentals Snapshot

Metric ELVN RXRX
Market Cap — —
Forward P/E -25.7 -4.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 2.6%
Gross Margin — -5.2%
Operating Margin 0.0% -6.6%
EPS -1.69 -0.86
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.